×
Future Health ESG EBIT 2022-2023 | FHLT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Future Health ESG ebit from 2022 to 2023. Ebit can be defined as earnings before interest and taxes.
View More
Future Health ESG EBIT 2022-2023 | FHLT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Future Health ESG ebit from 2022 to 2023. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$37.7B
Tempus AI (TEM)
$8B
Hims & Hers Health (HIMS)
$7B
Inspire Medical Systems (INSP)
$5.7B
IRhythm Technologies (IRTC)
$3.5B
Privia Health (PRVA)
$2.7B
Enovis (ENOV)
$2.7B
Azenta (AZTA)
$2.4B
Clover Health Investments (CLOV)
$2.2B
Omnicell (OMCL)
$2.1B
Schrodinger (SDGR)
$1.8B
10x Genomics (TXG)
$1.8B
Phreesia (PHR)
$1.7B
Butterfly Network (BFLY)
$748M
Standard BioTools (LAB)
$588M
Talkspace (TALK)
$537M
Fulgent Genetics (FLGT)
$515M
TruBridge (TBRG)
$362M
Nyxoah SA (NYXH)
$354M
Health Catalyst (HCAT)
$343M
SOPHiA GENETICS SA (SOPH)
$235M
Pulmonx (LUNG)
$230M
American Well (AMWL)
$169M
EUDA Health Holdings (EUDA)
$96M
P3 Health Partners (PIII)
$69M
CareCloud (CCLD)
$58M
HeartBeam (BEAT)
$58M
111 (YI)
$47M
Outset Medical (OM)
$44M
Zepp Health (ZEPP)
$42M